The FDA cleared FebriDx to be marketed by healthcare providers in urgent care and emergency care settings, the Australian-based company said in a July 3 news release. It’s meant to aid clinicians in diagnosing acute bacterial respiratory infections.
Lumos officials said the test can play an important role in antibiotic stewardship by aiding clinicians in differentiating between bacterial and viral-associated respiratory illness.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
